GNMSF
GENMAB A/S DKKstockOTC
EODNov 17, 2026
515.00USD-0.103%(-0.53)500
Loading…
Loading…
34.06B
Healthcare
Biotechnology
HQ
Copenhagen, Koebenhavn V, Denmark
1,846
Previous Close
$515.53
Beta
-0.42
52-Week High
$581.00 2026-10-28
52-Week Low
$232.34 2026-06-02
SMA 50
$374.87
SMA 200
$292.13
Avg. Vol 10D
2,768
Avg. Vol 30D
3,639
Avg. Vol 90D
3,088
Relative Vol
0.14
66.14M
58.24M
74,675
0.13%
4.35
729.0M
12.07
GNMSF Profile
founded in 1999, genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer. partnering of selected product candidates and technologies is a key focus of genmab's strategy and the company has alliances with top tier pharmaceutical and biotechnology companies. disclaimer: bit.ly/gendisclaimer
GNMSF Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 509.50 | 2026-11-12 | +1.08% | -1.435 |
| 1M | 378.00 | 2026-10-19 | +36.24% | -0.445 |
| 3M | 320.00 | 2026-08-18 | +60.94% | -0.706 |
| 6M | 269.50 | 2026-05-20 | +91.09% | -0.680 |
| 1Y | 306.00 | 2025-11-18 | +68.30% | -0.423 |
| 2Y | 210.76 | 2024-11-18 | +144.35% | — |
| 5Y | 421.58 | 2021-11-18 | +22.16% | -0.016 |
GNMSF Stock Summary
GENMAB A/S DKK (OTC:GNMSF) stock price today is $515.00, and today's volume is 500. GNMSF is down 0.103% today. The 30 day average volume is 3,639. GNMSF market cap is $34.06B with 66.14M shares outstanding.